Gabelli Funds’s GSK GSK Stock Holding History

Gabelli Funds’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$354K	Hold	6,760	–	–	﹤0.01%	1112
2026 Q1	$373K	Hold	6,760	–	–	﹤0.01%	1077
2025 Q4	$332K	Hold	6,760	–	–	﹤0.01%	1101
2025 Q3	$292K	Sell	6,760 -1,200	-15%	-$46.9K	﹤0.01%	1112
2025 Q2	$306K	Buy	7,960 +1,200	+18%	+$45.9K	﹤0.01%	1091
2025 Q1	$262K	Hold	6,760	–	–	﹤0.01%	978
2024 Q4	$229K	Sell	6,760 -440	-6%	-$15.8K	﹤0.01%	1004
2024 Q3	$294K	Hold	7,200	–	–	﹤0.01%	962
2024 Q2	$277K	Hold	7,200	–	–	﹤0.01%	956
2024 Q1	$309K	Hold	7,200	–	–	﹤0.01%	942
2023 Q4	$267K	Hold	7,200	–	–	﹤0.01%	972
2023 Q3	$261K	Hold	7,200	–	–	﹤0.01%	987
2023 Q2	$257K	Sell	7,200 -2,750	-28%	-$98.6K	﹤0.01%	992
2023 Q1	$354K	Sell	9,950 -2,200	-18%	-$77K	﹤0.01%	968
2022 Q4	$427K	Sell	12,150 -1,285	-10%	-$42.8K	﹤0.01%	956
2022 Q3	$395K	Buy	13,435 +1,675	+14%	+$63.5K	﹤0.01%	1028
2022 Q2	$640K	Sell	11,760 -880	-7%	-$48.6K	﹤0.01%	954
2022 Q1	$688K	Sell	12,640 -40	-0.3%	-$2.17K	﹤0.01%	985
2021 Q4	$699K	Sell	12,680 -12,440	-50%	-$647K	﹤0.01%	1001
2021 Q3	$1.2M	Sell	25,120 -17,560	-41%	-$882K	0.01%	859
2021 Q2	$2.12M	Buy	42,680 +4,280	+11%	+$206K	0.01%	739
2021 Q1	$1.71M	Hold	38,400	–	–	0.01%	771
2020 Q4	$1.77M	Sell	38,400 -2,220	-5%	-$102K	0.01%	750
2020 Q3	$1.91M	Sell	40,620 -1,540	-4%	-$77.2K	0.01%	694
2020 Q2	$2.15M	Sell	42,160 -600	-1%	-$30.8K	0.02%	643
2020 Q1	$2.02M	Buy	42,760 +8,200	+24%	+$437K	0.02%	637
2019 Q4	$2.03M	Buy	34,560 +25,080	+265%	+$1.4M	0.01%	725
2019 Q3	$506K	Sell	9,480 -2,400	-20%	-$123K	﹤0.01%	953
2019 Q2	$594K	Buy	11,880 +1,080	+10%	+$54.2K	﹤0.01%	964
2019 Q1	$564K	Buy	10,800 +2,000	+23%	+$99.9K	﹤0.01%	960
2018 Q4	$420K	Sell	8,800 -1,600	-15%	-$78.8K	﹤0.01%	993
2018 Q3	$522K	Hold	10,400	–	–	﹤0.01%	1004
2018 Q2	$524K	Hold	10,400	–	–	﹤0.01%	996
2018 Q1	$508K	Hold	10,400	–	–	﹤0.01%	993
2017 Q4	$461K	Hold	10,400	–	–	﹤0.01%	1008
2017 Q3	$528K	Hold	10,400	–	–	﹤0.01%	987
2017 Q2	$561K	Hold	10,400	–	–	﹤0.01%	982
2017 Q1	$548K	Hold	10,400	–	–	﹤0.01%	990
2016 Q4	$501K	Hold	10,400	–	–	﹤0.01%	1012
2016 Q3	$561K	Sell	10,400 -861	-8%	-$47.2K	﹤0.01%	1004
2016 Q2	$610K	Hold	11,261	–	–	﹤0.01%	994
2016 Q1	$571K	Hold	11,261	–	–	﹤0.01%	985
2015 Q4	$568K	Hold	11,261	–	–	﹤0.01%	981
2015 Q3	$541K	Hold	11,261	–	–	﹤0.01%	927
2015 Q2	$586K	Hold	11,261	–	–	﹤0.01%	956
2015 Q1	$650K	Hold	11,261	–	–	﹤0.01%	937
2014 Q4	$602K	Hold	11,261	–	–	﹤0.01%	952
2014 Q3	$647K	Hold	11,261	–	–	﹤0.01%	950
2014 Q2	$753K	Hold	11,261	–	–	﹤0.01%	920
2014 Q1	$752K	Hold	11,261	–	–	﹤0.01%	903
2013 Q4	$752K	Hold	11,261	–	–	﹤0.01%	883
2013 Q3	$706K	Hold	11,261	–	–	﹤0.01%	885
2013 Q2	$703K	Buy	+11,261	New	+$715K	﹤0.01%	871

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Gabelli Funds's GSK Position: Q2 2026 in Review

Gabelli Funds held its GSK (GSK) position steady in Q2 2026 at 6,760 shares worth $354K. The position accounts for ﹤0.01% of the portfolio, ranked #1112.

Gabelli Funds first reported a position in GSK in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.15M in Q2 2020. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Gabelli Funds held 6,760 shares of GSK worth $354K as of Q2 2026.
Gabelli Funds left its GSK share count unchanged in Q2 2026.
GSK made up ﹤0.01% of Gabelli Funds's portfolio in Q2 2026, its #1112 holding.
Gabelli Funds first reported a position in GSK in Q2 2013 and has held it in 53 quarters since.
Gabelli Funds's GSK position peaked at $2.15M in Q2 2020.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Gabelli Funds's 13F filing for Q2 2026, filed 12 Aug 2026.